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Abstract: Obesity can lead to pathological growth of adipocytes by inducing inflammation and
oxidative stress. Genistein could be a potential candidate for the treatment of obesity due to its
antioxidant properties. Specific kits were used to examine the effects of genistein vs adiponectin on
human visceral pre-adipocytes differentiation, cell viability, mitochondrial membrane potential, and
oxidative stress in pre-adipocytes and in white/brown adipocytes. Western Blot was performed to
examine changes in protein activation/expression. Genistein increased human visceral pre-adipocytes
differentiation and browning, and caused a dose-related improvement of cell viability and
mitochondrial membrane potential. Similar effects were observed in brown adipocytes and in
white adipocytes, although in white cells the increase of cell viability was inversely related to
the dose. Moreover, genistein potentiated AMP-activated protein kinase (AMPK)/mitofusin2
activation/expression in pre-adipocytes and white/brown adipocytes and protected them from
the effects of hydrogen peroxide. The effects caused by genistein were similar to those of adiponectin.
The results obtained showed that genistein increases human visceral pre-adipocytes differentiation
and browning, protected against oxidative stress in pre-adipocytes and white/brown adipocytes
through mechanisms related to AMPK-signalling and the keeping of mitochondrial function.
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1. Introduction
Obesity arises from the imbalance between energy intake and energy expenditure, and may lead to
a pathological growth of adipocytes [1–4]. Although the underlying mechanisms remain unclear [5,6],
growing evidence suggests that oxidative stress and mitochondrial dysfunction would act as key factor
in the pathophysiology of obesity and in the cross talk with its associated complications [2,5,7,8]. Also,
brown adipose tissue (BAT), the less represented type of visceral adipose tissue (VAT), could play a role
in body fat accumulation [6,9,10]. Hence, BAT cells can generate heat and fatty acid energy substrates
thanks to their large numbers of mitochondria in which oxidative phosphorylation is uncoupled
from ATP production as a result of a transmembrane proton leak mediated by uncoupling protein 1
(UCP1) [11]. Previous findings have shown that when BAT levels are either increased or decreased,
the protection against diet-induced obesity is affected [12].
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Extensive studies have focused on the role of nutritional factors in the etiology, prevention, and
treatment of obesity. In this context, genistein has emerged as a key agent amongst the various agents
examined [4,11–13]. Phytoestrogen genistein is one of several known isoflavones of soybeans and it
binds directly to estrogen receptors (ERs), thus exerting both estrogenic and anti-estrogenic effects [14].
Recent studies demonstrated that lifelong exposure to dietary isoflavones and phytoestrogens, which
is typical of traditional Asian diet, is linked to a lower obesity prevalence and obesity related
pathologies [15].
The protective effects elicited by genistein could be related to its effect on adipogenesis, which
would be inhibited by mechanisms related to 5’ adenosine monophosphate-activated protein kinase
α/β (AMPKα/β), [1,16,17]. Also, the anti-inflammatory and antioxidant properties exerted by
genistein in different cell types [18–20] could represent a mechanism leading to its protective effects.
So far however, information about those issue is scarce. Moreover, no data is available about its effects
on brown adipocytes.
Thus, in the present study we examined the effects of genistein on human visceral pre-adipocytes
differentiation towards white and brown adipose tissue, as well as its actions on cell viability,
mitochondrial membrane potential and oxidative stress of pre-adipocytes and white and brown
adipocytes. Moreover, the role of extracellular signal regulated phospho-Akt, mitofusin-2 (Mfn2), and
AMPKα/β expression or activation was analyzed.
2. Materials and Methods
2.1. Isolation of Pre-Adipocyte from Adipose Tissue
Human VAT samples were collected from 30 subjects undergoing general surgery for diverticulitis
and laparocele. Ethical approval and informed consent were obtained prior to surgery (The study
was approved by the Ethics Committee of the University Hospital Maggiore of Charity of Novara.
All participants provided written informed consent prior to participation). Men aged 50–70 were
included. Exclusion criteria were as follows: inability to give informed consent, underlying malignancy,
endocrinological disorders, diabetes, metabolic syndrome, smoking, and intake of cardiovascular
drugs, statins, hormonal agents, and corticosteroids. VAT tissue, approximately 10–20 g, was the excess
adipose tissue surrounding surgical specimens that have been removed during surgical procedures.
Human pre-adipocytes were isolated from adipose tissue by first washing the tissue sample extensively
with phosphate-buffered saline (PBS) containing 5% penicillin/streptomycin (P/S; Sigma, Milan, Italy).
In order to extract pre-adipocytes, the sample was minced using two scalpels and pipetted up and
down several times to facilitate the digestion in a sterile tissue culture plate with 2 mg/mL collagenase
Type I (Life Technologies, Monza, Italy) prepared in PBS containing 2% P/S for tissue digestion and
then put at 37 ◦C with 5% CO2 in incubator. After 2 h, collagenase Type I activity was neutralized
by adding to the tissue sample an equal volume of pre-adipocyte medium alpha minimum essential
medium (α-MEM; Sigma) supplemented with 20% fetal bovine serum (FBS; Euroclone, Pero, Milan,
Italy), 2 mM L-glutamine (Sigma) and 1% penicillin-streptomycin (Sigma). The sample was then
transferred to a 50 mL tube, avoiding the solid aggregates and centrifuged at 2000 rpm for 5 min.
After spinning, all the collagenase solution above the pellet was aspirated and resuspended in 3 mL
complete α-MEM supplemented with 20% FBS, and the cell suspension was filtered through 70 mm
cell strainer. The sample containing the cells was plated and incubated at 37 ◦C, 5% CO2 [21].
2.2. Culture, Expansion and Treatment of Pre-Adipocytes
Seventy-two hours after plating, the medium was aspirated from the plate. The cells were washed
with PBS supplemented with 1% P/S. The solution over the cell layer was pipetted several times
in order to clean the cells thoroughly from any tissue fragments and/or blood cells. A volume of
fresh α-MEM 10% FBS was added according to the well capacity of the culture plate. The cells were
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maintained at 37 ◦C with 5% CO2. The medium was changed every second day until the cells reached
80–90% confluence and then pre-adipocytes were used to perform the experiments.
For mitochondrial membrane potential measurement and cell viability, 20 × 104 cells/well were
plated in 12-well plates with complete α-MEM 10% FBS. The same procedure was followed for
reactive oxygen species (ROS) quantification, but using 30 × 103 cells/well. For Oil-Red O Staining Kit
(BioVision, Inc., San Francisco, CA, USA), 10× 104 cells/well were plated in 24-well plates. For Western
Blot, 40× 104 cells/well were used in 6-well plates. A pool of cells at confluence, which was considered
as day 0, was induced to differentiate by using α-MEM medium supplemented with hormone cocktail
containing 0.5 mM 3-isobutyl-1 methylxanthine (IBMX; Sigma), 0.5 µM dexamethasone (Sigma), 50 µM
indomethacin (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA). This medium was taken as
differentiation medium (DM) as previously performed [9,21]. After 48 h, this medium was replaced
every 2 days. Droplets began to appear 8 days after inducing differentiation and by day 14 cells
containing large lipid droplets were considered mature adipocytes [9]. In addition, another pool
of cells was also treated with 1 nM 3,3′,5-Triiodo-L-thyronine sodium salt (T3; Sigma), which was
added to DM in order to induce brown differentiation [6,9]. Following the procedure described above,
cells were maintained in this medium until exhibiting fully differentiated phenotype with massive
accumulation of multilocular fat droplets. All experiments were performed within 15 passages.
2.3. Oil-Red O Staining
We examined anti-obesity potential of genistein by determining pre-adipocyte differentiation
into adipocytes. Pre-adipocytes were treated with either genistein (10 pM, 1 µM, 50 µM and 200 µM;
Sigma) or adiponectin (100 µM; Sigma) for all the differentiating period. Control cells were treated
with DM only. On day 14, differentiation was over and fat drops were detected by Oil-Red O staining
(BioVision). According to the manufacturer’s instructions, the cells were washed with PBS and fixed
in 10% formalin for 30 min. After washing twice with PBS and once with 60% isopropanol, the cells
were then stained with Oil Red O Working Solution and incubated for 20 min. Afterward, the cells
were washed with dH2O until the excess stain was no longer evident and stained for nuclei with
hematoxylin solution for 1 min. At the end, cells were washed with dH2O and viewed under the
microscope. After staining with hematoxylin and washing with dH2O, cells were washed three times
with 60% isopropanol. Oil Red O stain was extracted with 100% isopropanol and 80% of extraction
volume was transferred in a 96-well to measure the absorbance at 492 nm by a spectrometer (BS1000
Spectra Count, San Jose, CA, USA). Experiments were repeated five times in pre-adipocytes taken
from each patient.
2.4. Cell Viability
Cell viability was examined by using the 1% 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium
bromide (MTT; Life Technologies, Italia, Monza, Italy) dye, as previously described [19,22,23] both
in pre-adipocytes and in white adipocytes (treated with DM) and in brown adipocytes (treated with
DM supplemented with 1 nM T3). Pre-adipocytes/adipocytes were treated in physiological and
peroxidative conditions with adiponectin (100 µM; Sigma) and genistein at different doses (10 pM,
1 µM, 50 µM and 200 µM; Sigma) for 30 min. Control cells were treated with α-MEM/DM only.
Oxidative stress was generated in pre-adipocytes/adipocytes by 200 µM hydrogen peroxide (H2O2)
for 30 min alone or in the presence of genistein and adiponectin. The antioxidant N acetyl-cysteine
(NAC; Sigma) was used as positive control. In some experiments the effects of 200 µM genistein on cell
viability were also examined in the presence of equimolar wortmannin and dorsomorphin (Sigma),
the Akt and AMPKα/β inhibitors, respectively. After each treatment, the treatment medium was
removed, and fresh culture medium α-MEM without FBS and with MTT dye was added in 24-well
plates containing the cells and incubated for 2 h at 37 ◦C in an incubator. Thereafter, the medium was
removed, and 50 µL dimethyl sulfoxide (DMSO; Sigma) was added and mixed in a gyratory shaker
until the complete dissolution of formazan crystals. Cell viability was determined by measuring
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the absorbance through a spectrometer (BS1000 Spectra Count), and cell viability was calculated by
comparing results with control cells. Experiments were repeated five times in pre-adipocytes taken
from each patient.
2.5. Mitochondrial Membrane Potential Measurement
Mitochondrial membrane potential measurement was performed with JC-1 assay as previously
described for cell viability. After stimulation, the treatment medium was removed and cells
were incubated with 5,51,6,61-tetrachloro-1,11,3,31 tetraethylbenzimidazolyl carbocyanine iodide
(JC-1) 1X diluted in Assay Buffer 1X for 15 min at 37 ◦C, following the manufacturer’s instruction
and as previously performed (Invitrogen, Life Technologies Europe BV, Monza, Italy) [19,22,23].
After incubation, the cells were washed twice with Assay Buffer 1× and then the mitochondrial
membrane potential was determined by measuring the red (excitation 550 nm/emission 600 nm)
and green (excitation 485 nm/emission 535 nm) fluorescence through a spectrometer (BS1000 Spectra
Count). To assess cells that had apoptosis, the ratio of red to green fluorescence was determined
and expressed as a percentage. Experiments were repeated five times in pre-adipocytes taken from
each patient.
2.6. ROS Quantification
The oxidation of 2,7-dichlorodihydrofluorescein diacetate (H2DCFDA) into 2,7-
dichlorodihydrofluorescein (DCF) was used to assess ROS generation, following the manufacturer’s
instructions (Abcam, Cambridge, UK). Experimental protocol was the same as that followed for cell
viability and mitochondrial membrane potential but without the use of inhibitors. After treatments,
the reactions were stopped by removing the medium and washing with PBS, which was followed by
staining with 10 µM H2DCFDA for 20 min at 37 ◦C. The fluorescence intensity of H2DCFDA was
measured at an excitation and emission wavelength of 485 nm and 530 nm using a spectrometer,
as previously performed (BS1000 Spectra Count) [19,22,23]. Experiments were repeated five times in
pre-adipocytes taken from each patient.
2.7. Cell Lysates
For Western blot analysis, pre-adipocytes/adipocytes were treated in physiological and
peroxidative conditions with genistein (10 pM and 200 µM; Sigma) and adiponectin (100 µM; Sigma) as
described above. At the end of stimulation, pre-adipocytes/adipocytes were lysed in iced-Ripa-buffer
supplemented with sodium orthovanadate (2 mM; Sigma) and protease inhibitors cocktail (1 mM;
Thermo Fisher Scientific, Waltham, MA, USA) and phenylmethanesulfonyl fluoride (1 mM; Sigma).
The extracted proteins were quantified through bicinchoninic acid protein (BCA, Pierce, Rockford, IL,
USA) and used for electrophoresis and immunoblotting studies. Experiments were repeated five times
in pre-adipocytes taken from each patient.
2.8. Western Blotting
Cell lysates (30 µg protein each sample) dissolved in Laemmli buffer 5×, boiled for 5 min were
resolved in 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis gels (SDS-PAGE, Bio-Rad
Laboratories, Hercules, CA, USA). After electrophoresis they were transferred to polyvinylidene
fluoride membranes (PVDF, Bio-Rad Laboratories), which were incubated overnight at 4 ◦C with
specific primary antibodies: anti phospho-Akt (p-Akt; 1:1000; Ser473, Santa Cruz Biotechnology, Inc.,
Santa Cruz, CA, USA), anti Akt (1:1000; Santa Cruz Biotechnology), anti UCP1 (1:1000; 4E5, Santa
Cruz Biotechnology), anti p-AMPKα/β (1:1000; D-6, Santa Cruz Biotechnology), AMPKα/β (1:1000;
Santa Cruz Biotechnology), anti Mfn2 (1:1000; H-68, Santa Cruz Biotechnology). The membranes
were washed and then incubated with horseradish peroxidase-coupled goat anti-rabbit IgG (Sigma),
peroxidase-coupled rabbit anti-goat IgG and horseradish peroxidase-coupled goat anti-mouse IgG
(Sigma) for 45 min and were developed through a nonradioactive method using Western Lightning
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Chemiluminescence (PerkinElmer Life and Analytical Sciences, Waltham, MA, USA). Phosphorylated
protein expression was calculated as a ratio towards specific total protein or β-actin (1:5000; C4,
Santa Cruz Biotechnology).
2.9. Statistical Analysis
All data were recorded using the Institution’s database. Statistical analysis was performed by
using STATVIEW version 5.0.1 for Microsoft Windows (SAS Institute Inc., Cary, NC, USA). Data were
checked for normality before statistical analysis. All the results obtained were examined through
one-way ANOVA followed by Bonferroni post hoc tests. The non-parametric Mann Whitney U test for
unpaired data was used to compare percentage responses. All data are presented as means ± standard
deviation (SD) of five independent experiments for each experimental protocol executed in adipocytes
taken from each patient. A value of p < 0.05 was considered statistically significant.
3. Results
3.1. Effects of Genistein on Human Visceral Pre-Adipocytes Differentiation in Physiological Conditions
As shown in Figure 1, in physiological conditions 10 pM and 1 µM genistein increased human
visceral pre-adipocytes differentiation in a similar way to adiponectin. In contrast, the differentiation
observed with genistein 50 µM and 200 µM was lower, although still higher than the control.
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differentiation by using Oil Red O Staining: In , effects of genistein (G) 10 pM, 1 µM, 50 µM and
200 µM, adiponecti ( dipo; 100 µM) for all the differe tiating period. C = control (pr -adipocytes
treated only with differentiation edium). Reported data are means ± SD of fiv independent
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groups (p < 0.05). In (B), in each panel one example for each treatment is reported. The images were
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3.2. Effects of Genistein on Cell Viability and Mitochondrial Membrane Potential in Human Visceral
Pre-Adipocytes/Adipocytes Cultured in Physiological and Peroxidative Conditions
As shown in Figure 2A, in pre-adipocytes cultured in physiological conditions, adiponectin
increased cell viability of about 11% in comparison with the control, without affecting mitochondrial
membrane potential (Figure 2B). Genistein reduced cell viability up to 50 µM and increased it at
200 µM (Figure 2A). Moreover, an improvement of mitochondrial membrane potential was observed
from 1 µM genistein concentration upwards (Figure 2B). The effects of genistein were abolished by
both wortmannin and dorsomorphin (Figure 2A,B).
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Figure 2. Effects of genistein in pre-adipocytes, cultured in physiological condition, on cell viability (A)
and mitochondrial membrane potential (B): In A and B, the effects of genistein (G) 10 pM, 1 µM, 50 µM
and 200 µM, adiponectin (Adipo; 100 µM), wortmannin (W; 200 µM), dorsomorphin (D; 200 µM).
C = control. Reported data are means ± SD of five independent experiments for each experimental
protocol executed in adipocytes taken from each patient. Significance between groups: # p < 0.05
vs. control; * p < 0.05 vs. Adipo 100 µM. Short square brackets indicate significance between groups
(p < 0.05).
Regarding white adipocytes cultured in physiological conditions, adiponectin augmented cell
viability and mitochondrial membrane potential respectively by about 39% and 44% (Figure 3A,B).
Also, genistein increased cell viability at concentration up to 50 µM (Figure 3A) in a way that was
inversely related to the dose. However, only 10 pM genistein caused an improvement of mitochondrial
membrane potential (Figure 3B). As observed for pre-adipocytes, wortmannin, and dorsomorphin
abolished the increase of cell viability caused by genistein (Figure 3A).
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Regarding brown adipocytes cultured in physiological conditions, a slight increase of cell viability
and an improvement of about 41% in mitochondrial membrane potential were found in response to
adiponectin. Also, genistein caused a concentration-dependent increase of both cell viability (Figure 3C)
and mitochondrial membrane potential (Figure 3D). Those effects were abolished in brown adipocytes
treated with wortmannin and dorsomorphin (Figure 3C,D).
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Figure 3. Effects of genistein in white adipocytes, cultured in physiological condition, on cell viability
(A) and mitochondrial membrane potential (B), and in brown adipocytes, on cell viability (C) and
mitochondrial membrane potential (D). Abbreviations are as in Figures 1 and 2. Reported data are
means ± SD of five independent experiments for each experimental protocol executed in adipocytes
taken from each patient. Significance between groups: # p < 0.05 vs. control; * p < 0.05 vs. Adipo
100 µM. Short square brackets indicate significance between groups (p < 0.05).
Furthermore, in pre-adipocytes (Figure 4A), adiponectin counteracted the effects of 200 µM
hydrogen peroxide on cell viability. In white and brown adipocytes, similar findings were observed
not only on cell viability but also on mitochondrial membrane potential (Figure 5). As observed with
adiponectin, also genistein exerted protection against peroxidation. In particular, in pre-adipocytes,
all doses of genistein incre sed cell viability (Figure 4A) and mitochondrial membrane potential
(Figure 4B). In white adipocy s, the effects on cell viability of genistein were similar to those of
adiponectin for concentration up to 1 µM (Figure 5A). In respect of mitochondrial membran potential,
the effects of genistein were lower than the ones caused by adiponectin and were inversely related to
the dose (Figure 5B). In brown adipocytes, all doses of genistein were more effective than adiponectin
in increasing cell viability (Figure 5C). In contrast, only 200 µM genistein exerted higher effects on
mitochondrial membrane potential in comparison with adiponectin (Figure 5D).
It is notable that the protective effects elicited by 200 µM genistein on cell viability were similar
to those caused by 200 µM NAC in pre-adipocytes and brown adipocytes (Figures 4A and 5C).
Also regarding mitochondrial membrane potential, in white and brown adipocytes 200 µM genistein
and 200 µM NAC elicited similar protective effects (Figure 5B,D). In contrast, in pre-adipocytes, NAC
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was more effective than genistein in preventing the collapse of mitochondrial membrane potential
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# p < 0. 5 vs. control; ## p < 0.05 v . H2O2 200 µM; ** p < 0.05 vs. Adipo 100 µM + H2O2 200 µM. Short
square brackets indicate significance between groups (p < 0.05).
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mitochondrial membrane potential (D). Abbreviations are as in previous figures. Reported data are
means ± SD of five independent experiments for each experimental protocol executed in adipocytes
taken f m each patient. Significance between groups: # p < 0.05 vs. control; ## p < 0.05 vs. H2O2
200 µM; ** p < 0.05 vs. Adipo 100 µM + H2O2 200 µM. Short square brackets indicate significance
between groups (p < 0.05).
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3.3. Effects of Genistein on ROS Production in Human Visceral Pre-Adipocytes/Adipocytes Cultured in
Peroxidative Conditions
As shown in Figure 6, adiponectin reduced ROS production caused by 200 µM H2O2 in
pre-adipocytes (Figure 6A) and in both white (Figure 6C) and brown (Figure 6D) adipocytes. Those
effects were lower than those caused by NAC (Figure 6A,C,D). Moreover, in white adipocytes, genistein
reduced ROS production caused by 200 µM H2O2 in a way that was inversely related to the dose.
Similar findings were observed in pre-adipocytes and brown adipocytes although they were related
to the dose of genistein. It is to note that in physiological conditions, only concentration higher than
50 µM genistein was able to reduce ROS release (Figure 6B).
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control; * p < 0.05 vs. Adipo 100 µM; ## p < 0.05 vs. H2O2 200 µM; ** p < 0.05 vs. Adipo 100 µM + H2O2
200 µM. Short square brackets indicate significance between groups (p < 0.05).
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3.5. Involvement of Akt, Mfn2, and AMPKα/β in the Effects of Genistein in Human Visceral
Pre-Adipocytes/Adipocytes Cultured in Physiological and Peroxidative Conditions
Adiponectin increased Akt activation in white (Figure 8B) and brown (Figure 8C) adipocytes, and
Mfn2 expression in white adipocytes only (Figure 9B). In pre-adipocytes, cultured in physiological
conditions, only 200 µM genistein was able to increase Akt activation and Mfn2 expression (Figures 8A
and 9A). In addition, whil in white adipocytes cultured in physiological conditio s only 10 pM
genistein augmented Akt activation (Figure 8B), all doses of genistein exer d this eff ct in brown
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adipocytes (Figure 8C). It is also to note that in adipocytes, an increase of Mfn2 expression was
observed in response to all doses of genistein (Figure 9B,C). Finally, both adiponectin and genistein
prevented the effects of hydrogen peroxide on Akt activation and Mfn2 expression (Figures 8 and 9).
On the other hand, in pre-adipocytes (Figure 10A), and in white (Figure 10B) and in brown (Figure 10C)
adipocytes, the pretreatment with genistein and adiponectin improved the activation of AMPKα/β
and counteracted the effects of H2O2.
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Figure 9. Effects of genistein on Mfn2 expression in pre-adipocytes (A), white adipocytes (B) and
brown adipocytes (C), cultured in physiological and peroxidative conditions: Abbreviations are as in
previous figures. Reported data are means± SD of five independent experiments for each experimental
protocol executed in adipocytes taken from each patient. Significance between groups: # p < 0.05 vs.
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200 µM. Short square brackets indicate significance between groups (p < 0.05).
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4. Discussion
This study has shown that genistein increases differentiation and browning of human visceral
pre-adipocytes and exerts positive effects on cell viability and mitochondrial membrane potential in
either white or brown adipocytes. Furthermore, genistein is effective in protection against peroxidation
by inhibition of ROS release and preserving mitochondrial function, as shown by Mfn2 expression
modulation in both pre-adipocytes and adipocytes.
Genistein, the most abundant soy-derived isoflavone that shares structural similarities with 17 β
estradiol has various biological activities, amongst which is the inhibition of adipogenesis in various
cellular models [14,24–26]. Its inhibitory effects on adipocyte metabolism and maturation could be the
underlying mechanism of its protection against cardiovascular diseases or metabolic syndrome [27].
The results we have obtained in human visceral pre-adipocytes are in disagreement with previous
observations, since the pretreatment of cells with genistein at doses that have been widely used for
similar studies [28] increased pre-adipocytes differentiation, as shown by Oil Red staining. Those
effects were not different from the ones elicited by adiponectin, for genistein concentration up to 1 µM.
Meanwhile, genistein increased the browning of pre-adipocytes, as shown by the augmented UCP1
expression [29,30].
Also, our results regarding Mfn2 and mitochondrial membrane potential in human visceral
pre-adipocytes treated with genistein could be considered as a marker of browning. Our data would
be in agreement with previous studies, showing that Mfn2 is highly expressed in BAT, where it would
act as a mediator of mitochondrial interaction with lipid droplets and as a modulator of whole-body
energy homeostasis [31,32].
The discovery that white adipocytes can undergo a browning process to become metabolically
active beige cells has attracted significant interest in the fight against obesity [33]. Hence, differently
from white adipocytes, which are responsible for energy storage, brown adipocytes are key regulators
in the dissipation of chemical energy as heat. In this process, UCP1, a widely accepted genetic marker
of brown adipocytes, [29] would be highly involved [30].
As previously shown, AMPKα/β was found to be activated by genistein in human visceral
pre-adipocytes. AMPKα/β represents a metabolite-sensing protein kinase [34] that is widely involved
in the regulation of energy homeostasis in various ATP-depleting metabolic states, such as those found
in hypoxia and oxidative stress [35]. For this reason, AMPKα/β cascades have emerged as novel
targets for the treatment of obesity and type 2 diabetes [36]. It is to note that AMPKα/β activation was
reported to be implicated in the inhibition of adipocyte differentiation [37] by mechanisms related to
increased ROS release [1].
In our study, genistein augmented AMPKα/β activation in human visceral pre-adipocytes
cultured in physiological condition while causing no effect or reducing ROS generation, which
could account for the differences we have found in differentiation. A more complex role played
by AMPKα/β in the modulation of adipogenesis through ROS release would be involved. It is also
of note that our results were obtained in human primary cells and not in 3T3-L1 pre-adipocytes, as
performed in those studies. Thus, differences in the biological behavior related to the cellular type and
different experimental conditions could account for the discrepancies we have found.
Moreover, since Akt activation would play an important role in human adipogenesis [38]
our results about Akt could at least explain the effects of the highest dose genistein on human
pre-adipocytes differentiation, too.
It is of note that, unlike genistein, the effects of adiponectin on human visceral pre-adipocytes
differentiation were only accompanied by an increase AMPKα/β activation and of UCP1 expression.
The finding about increased adipogenesis of adiponectin is in agreement with the previous ones
obtained in 3T3-L1 [39]. Also, the effects of adiponectin on AMPKα/β would confirm previous data,
although they were related to the lipolytic action exerted by the adipokine in adipose tissue [40].
Further studies would thus be necessary to clarify the cross talk between AMPKα/β and Akt in
adipogenesis in human visceral adipose tissue.
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In adipocytes, different results were obtained between white or brown cells. Hence, in white
adipocytes cultured in physiological conditions an inverse dose related response on cell viability
was observed. Only a slight increase in mitochondrial membrane potential were found with 10 pM
genistein. In brown adipocytes, the protective effects on cell viability were related to the dose and
all doses genistein improved mitochondrial membrane potential. Those effects were accompanied
by an increased activation of Akt and by an augmented expression of Mfn2, which was particularly
evident for brown adipocytes, as mentioned above. In peroxidative conditions, genistein protected
both white and brown adipocytes against the lost cell viability and the collapse of mitochondrial
membrane potential. This protection was also evident in human visceral pre-adipocytes. Moreover,
a reduction of hydrogen peroxide-related ROS release was found. It is to note that although genistein
was less effective than NAC in reducing ROS release, it was able to exert similar protective effects on
cell viability and mitochondrial membrane potential as those elicited by NAC, particularly in brown
adipocytes, which would highlight the protective role of genistein as antioxidant agent.
As observed for pre-adipocytes, also in adipocytes the effects elicited by genistein were partly
similar to those caused by adiponectin. Hence, in white and brown adipocytes the adipokine increased
cell viability, mitochondrial membrane potential and augmented Akt and AMPKα/β activation;
however only an increase of Mfn2 was found in white adipocyte. The involvement of Akt and
AMPKα/β was confirmed by experiments performed with specific inhibitors. Hence, in the presence
of wortmannin and dorsomorphin the effects of genistein were generally reduced or abolished in
either pre-adipocytes or white/brown adipocytes. Moreover, a protection against peroxidation was
observed. Our data add new information about those issues. Hence, few reports available in chicken
adipocytes have shown that adiponectin could prevent the reduction of lipid-induced mitochondrial
biogenesis by AMPK related signaling [41]. AMPK would also be involved in its effects on the insulin
sensitivity of 3T3-L1 adipocytes. [42].
In addition, the data obtained with JC-1 would be in agreement with previous findings showing
that the preservation of mitochondrial function could play a role in the protection exerted by
adiponectin [43].
Regarding the mechanisms of action leading to the beneficial effects exerted by genistein, a role
for Akt, AMPKα/β and Mfn2 could be hypothesized. Indeed, Akt is a well-known member of the
reperfusion injury salvage kinase pathway that could play an essential role in the modulation of
insulin sensitivity of adipocytes. In 3T3-L1 adipocytes, paraquat-induced oxidative stress decreased
glucose transporter 4 translocation to the cell surface by inhibition of the phosphorylation of Akt [44].
Although not clearly examined, and in agreement with previous findings [45], our data showing the
increased phosphorylation of Akt would highlight a beneficial role for genistein in preserving insulin
signaling and glucose uptake against oxidative stress in human adipocytes, as well. Also, in the case of
adiponectin, the protective effects observed against peroxidation in white and brown adipocytes could
be related to the increased Akt activation. These data would, on the other hand, confirm previous ones
about the beneficial effects exerted by adiponectin on the cardiovascular system [46,47].
As mentioned above, Mfn2 is a mitochondrial membrane protein that is crucial in mitochondrial
fusion, and loss of its function can greatly damage the mitochondrial network in several cell types.
It is also to note that Mfn2 has recently been described as a regulator of hormone-stimulated lipolysis
by acting as an A-kinase anchoring protein on the surface of the lipid droplets [48]. Therefore, changes
in Mfn2 observed in oxidative stress conditions could account for the altered lipid metabolism found
in the metabolic syndrome or diabetes [49]. Our data would be in agreement with those observations.
Hence, in our study, genistein counteracted the reduction of Mfn2 expression caused by peroxidation
in human visceral pre-adipocytes and adipocytes. Those effects were accompanied by the preservation
of a mitochondrial function and reduced ROS release. Further experiments would be necessary to
better understand the role of Mfn2 in mediating the beneficial effects of genistein in lipid metabolism
in human visceral adipocytes.
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All together our findings would highlight a role for genistein as a promising compound for the
treatment of diabetes or metabolic disorders through the modulation of mitochondrial network. Hence,
genistein would increase the browning in human visceral pre-adipocytes and exert protection against
oxidative damage in pre-adipocytes and mature adipocytes too, by mechanisms related to Akt and
AMPKα/β activation and the modulation of mitochondrial fusion.
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